Cellino

About:

Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies.

Website: https://www.cellinobio.com

Twitter/X: cellinobio

Top Investors: Khosla Ventures, 8VC, Advanced Research Projects Agency for Health, Felicis, Leaps by Bayer

Description:

Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.

Total Funding Amount:

$123M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)cellinobio.com

Founders:

Marinna Madrid, Matthias Wagner, Nabiha Saklayen, Stan Wang

Number of Employees:

11-50

Last Funding Date:

2024-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai